Roivant Sciences (ROIV) Proxy filing summary

Executive summary

• Annual General Meeting scheduled for September 16, 2026, in London, with voting available online or in person.

• Shareholders are encouraged to review proxy materials and vote by September 15, 2026.

Voting matters and shareholder proposals

• Election of two nominees, Daniel Gold and Meghan FitzGerald, as Class II Directors for a three-year term.

• Ratification of Ernst & Young LLP as independent auditor for the fiscal year ending March 31, 2027, including statutory appointment and remuneration authorization.

• Advisory, non-binding vote on executive compensation for named executive officers.

• Proxies may vote on other business as may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and proposals.